SCHEMBL7197953

SCHEMBL7197953

CCOC(=O)C1=C(B2OC(C)(C)C(C)(C)O2)CCN(C(=O)OCc2ccccc2)C1.CCOC(=O)C1=C(OS(=O)(=O)C(F)(F)F)CCN(C(=O)OCc2ccccc2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 8/20 0.39
SIGMAR1 Q99720 8/20 0.39
NR1H2 P55055 1/20 0.39
NR1H3 Q13133 1/20 0.39
HTR1A P08908 1/20 0.36
CHRM5 P08912 1/20 0.36
SLC6A2 P23975 1/20 0.36
HRH2 P25021 1/20 0.36
ADRA1D P25100 1/20 0.36
HTR1B P28222 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR1E P28566 1/20 0.36
HRH1 P35367 1/20 0.36
HTR2B P41595 1/20 0.36
SLC6A3 Q01959 1/20 0.36
CXCR3 P49682 1/20 0.35
PTGDR2 Q9Y5Y4 5/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4405414 0.89 TMEM97 (0.45) TMEM97SIGMAR1NR1H2NR1H3HTR1A
SCHEMBL4399041 0.89 TMEM97 (0.45) TMEM97SIGMAR1HTR1ACHRM5SLC6A2
SCHEMBL7103546 0.84 TMEM97 (0.42) TMEM97SIGMAR1HTR1ACHRM5SLC6A2
SCHEMBL13382410 0.81 TMEM97 (0.46) TMEM97SIGMAR1PTGDR2MEN1KMT2A
SCHEMBL18767256 0.81 RAB9A (0.43) TMEM97SIGMAR1HTR1ASLC6A2HRH2
SCHEMBL23924514 0.74 TMEM97 (0.46) TMEM97SIGMAR1PTGDR2MEN1KMT2A
SCHEMBL3992432 0.74 ADORA1 (0.37) CHRM5MEN1KMT2AGAATSHR
SCHEMBL1901800 0.73 MEN1 (0.48) CHRM5MEN1KMT2ACYP2C19
SCHEMBL2486254 0.73 MEN1 (0.48) SIGMAR1CHRM5MEN1KMT2ACYP2C19
SCHEMBL1081654 0.73 ADORA1 (0.47) NR1H2MEN1KMT2ANPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296972-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS Aventis Pharmaceuticals Inc. (US) 2003-04-02 EP disclosed
WO-2001090101-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2001-11-29 WO disclosed